News - Licensing, Ipsen

Filter

Current filters:

LicensingIpsen

Popular Filters

PeptiDream and Ipsen expand their peptide drug collaboration to treat endocrinologic disease

07-10-2013

PeptiDream and Ipsen have expanded the scope of their April 2013 research collaboration and license option…

Asia-PacificGastro-intestinalsIpsenLicensingPeptiDreamPharmaceutical

News briefs on Ipsen/Galderma and YM BioSciences nimotuzumab assets

04-12-2012

French drugmaker Ipsen (Euronext: IPN) and Switzerland-headquartered Galderma have expanded their collaboration…

Asia-PacificBiotechnologyCIMABDysportGaldermaInnoKeys PTEIpsenLicensingnimotuzumabOncologyPharmaceuticalSouth AmericaYM Biosciences

Ipsen and Inspiration renegotiate hemophilia agreement

22-08-2012

French drugmaker Ipsen (Euronext: IPN) said yesterday that it has renegotiated its 2010 strategic partnership…

FinancialIB1001Inspiration BiopharmaceuticalsIpsenLicensingOBI-1Pharmaceutical

Ipsen returns rights to Parkinson’s drug to Santhera

26-01-2012

Switzerland’s Santhera Pharmaceuticals (SIX:SANN) and French drugmaker Ipsen (Euronext: IPN) have…

fipamezoleIpsenLicensingNeurologicalPharmaceuticalSanthera Pharmaceuticals

Ipsen and Oncodesign collaborate on Parkinson's disease target

05-01-2012

French companies Oncodesign and Ipsen (Euronext: IPN) have entered into a research collaboration to discover…

IpsenLicensingNeurologicalOncodesignPharmaceuticalResearch

Vernalis jumps on deal with Genentech

05-01-2012

The UK's Vernalis (LSE: VER) saw its shares jump more than 5% to 20.75 yesterday, after the company revealed…

FinancialGenentechIpsenLicensingLundbeckPharmaceuticalRocheVernalis

Inspiration gets $25 million milestone from hemophilia collaboration partner Ipsen

30-11-2011

Privately-held US firm Inspiration Biopharmaceuticals says it has initiated patient enrollment in the…

Inspiration BiopharmaceuticalsIpsenLicensingPharmaceuticalResearch

Syntaxin and Ipsen in up to $99 million collaboration on novel botulinum-toxin therapeutics

21-10-2011

French drugmaker Ipsen (Euronext: IPN) has entered into a global strategic collaboration with privately-held…

BiotechnologyIpsenLicensingPharmaceuticalResearchSyntaxin

Inspiration Biopharma earns $35 million milestone from Ipsen on acceptance of hemophilia drug MAA

03-10-2011

French drugmaker Ipsen (Euronext: IPN) and its partner, privately-held Inspiration Biopharmaceuticals…

Cardio-vascularEuropeInspiration BiopharmaceuticalsIpsenLicensingPharmaceuticalRegulation

Ipsen enters deal with Photocure to commercialize Hexvix

28-09-2011

French drugmaker Ipsen (Euronext: IPN) has entered into a partnership with Norway-based Photocure (OSE:…

HexvixIpsenLicensingOncologyPharmaceuticalPhotocure

Ipsen leaps on strong first-half results; expands links with Inspiration Biopharma and names new CFO

31-08-2011

On a very busy news days for French drugmaker Ipsen (Euronext: IPN), the company saw its shares jump…

FinancialInspiration BiopharmaceuticalsIpsenLicensingManagementPharmaceutical

Back to top